Voie dopaminergique And NotM. H. Bhatt
List of bibliographic references
Number of relevant bibliographic references: 16.| Ident. | Authors (with country if any) | Title |
|---|---|---|
| 000147 | Marie-Anne El Khoury [France] ; Victor Gorgievski [France] ; Larissa Moutsimilli [France] ; Bruno Giros [France, Canada] ; Eleni T. Tzavara [France] | Interactions between the cannabinoid and dopaminergic systems: Evidence from animal studies |
| 000838 | J. E. Nash [Canada] ; P. Ravenscroft [Royaume-Uni] ; S. Mcguire [Royaume-Uni] ; A. R. Crossman [Royaume-Uni] ; F. S. Menniti [États-Unis] ; J. M. Brotchie [Canada] | The NR2B-selective NMDA receptor antagonist CP-101,606 exacerbates L-DOPA-induced dyskinesia and provides mild potentiation of anti-parkinsonian effects of L-DOPA in the MPTP-lesioned marmoset model of Parkinson's disease |
| 000993 | Vincenzo Di Matteo [Italie] ; Marisa Cacchio [Italie] ; Camillo Di Giulio [Italie] ; Ennio Esposito [Italie] | Role of serotonin2C receptors in the control of brain dopaminergic function |
| 000A78 | Doris J. Doudet [Canada] | Monitoring disease progression in Parkinson's disease |
| 000B38 | Vesna Sossi [États-Unis] ; Doris J. Doudet [Canada] ; James E. Holden [États-Unis] | A reversible tracer analysis approach to the study of effective dopamine turnover |
| 000B68 | M. Grandbois [Canada] ; M. Morissette [Canada] ; S. Callier [Canada, France] ; T. Di Paolo [Canada] | Ovarian steroids and raloxifene prevent MPTP-induced dopamine depletion in mice |
| 000C35 | J. B. A. Habraken [Pays-Bas, Canada] ; J. Booij ; P. Slomka ; E. B. Sokole ; E. A. Van Royen | Quantification and visualization of defects of the functional dopaminergic system using an automatic algorithm |
| 000C53 | G. D. Muir [Canada] ; I. Q. Whishaw [Canada] | Ground reaction forces in locomoting hemi-parkinsonian rats : a definitive test for impairments and compensations |
| 000D79 | I. Q. Whishaw [Canada] ; B. L. K. Coles [Canada] ; S. M. Pellis [Canada] ; E. I. Miklyaeva [Canada] | Impairments and compensation in mouth and limb use in free feeding after unilateral dopamine depletions in a rat analog of human Parkinson's disease |
| 000E44 | M.-A. Bedard [Canada] ; M. Panisset | Neurochimie des troubles cognitifs dans la maladie de Parkinson |
| 000E88 | E. Scarr [Canada] ; D. M. Wingerchuk ; A. V. Juorio ; I. A. Paterson | The effects of monoamine oxidase B inhibition on dopamine metabolism in rats with nigro-striatal lesions |
| 000E93 | M.-C. Asselin [Canada] ; J.-J. Soghomonian ; P.-Y. Côte ; A. Parent | Striatal changes in preproenkephalin mRNA levels in parkinsonian monkeys |
| 000F58 | A. J. Flint [Canada] ; S. E. Black ; I. Campbell-Taylor ; G. F. Gailey ; C. Levinton | Abnormal speech articulation, psychomotor retardation, and subcortical dysfunction in major depression |
| 000F60 | H. Hoshi [Canada] ; H. Kuwabara ; G. Leger ; P. Cumming ; M. Guttman ; A. Gjedde | 6-[18F]fluoro-L-DOPA metabolism in living human brain : a comparison of six analytical methods |
| 001146 | A. E. Lang | Manipulating the dopaminergic system in Parkinson's disease |
| 001182 | M. Takada ; T. Hattori | Collateral projections from the substantia nigra to the cingulate cortex and striatum in the rat |
| This area was generated with Dilib version V0.6.29. |  |